Abstracts tagged "COVID-19"

Abstract Number: 0015 • ACR Convergence 2020
COVID -19 Lung Inflammation – What Have We Learnt so Far ?
Sriya Gokaraju¹, Maria Darda², Vinod Vijayaraghavan Nalini Warrier³, Irina Duta³, Fiona Hayes³, Yasser Ahmed⁴ and Gouri Koduri³, ¹Southend University Hospital NHS Trust, Essex, United Kingdom, ²Southend University Hospital NHS Trust, Essex, United Kingdom, ³Southend University Hospital NHS Trust, Essex, United Kingdom, ⁴Southend University Hospital, Essex, United Kingdom
Background/Purpose: The SARS CoV-2 pandemic has inspired new interest in understanding the fundamental pathology of pneumonia and Acute Respiratory Distress Syndrome (ARDS). SARS CoV-2 in…
Abstract Number: 0435 • ACR Convergence 2020
Low Incidence of Coronavirus Disease 2019 (COVID-19) Infection in Patients on Biologic Infusion Therapies at a Community Rheumatology Practice
Julie Keegan Strosser¹, Ronald Yglesias² and Norman Gaylis¹, ¹Arthritis & Rheumatic Disease Specialties, Aventura, FL, ²Arthritis & Rheumatic Disease Specialties, Hialeah, FL
Background/Purpose: Following the first documented Florida case of COVID-19 on March 1, 2020, our community rheumatology practice continued to administer biologic infusion therapy with concern…
Abstract Number: 0595 • ACR Convergence 2020
High Satisfaction with Tele-medicine in a New York City Clinic
Tommy Chen¹, Cathy Guo¹, Wei Tang¹, Leila Khalili¹ and Anca Askanase², ¹Columbia University Medical Center, New York, NY, ²Columbia University College of Physicians & Surgeons, New York, NY
Background/Purpose: The face of medicine is changing with the time. A twenty-first century technological revolution in medicine happened in March 2020 as the COVID-19 pandemic…
Abstract Number: 0639 • ACR Convergence 2020
Immunological Abnormalities in a SARS-CoV-2-Cytokine Release Syndrome Rheumatology Cohort
Patil Injean¹, Sandy Lee¹, Neha Chiruvolu², Muntarin Karim³, Loomee Doo⁴, Deepa Ragesh Panikkath⁵, Donna Jose⁴, Micah Yu⁴, Anna Lafian⁴, Vaneet Sandhu⁶, Karina Torralba⁷, Christina Downey¹, Marven Cabling⁸ and Mehrnaz Hojjati⁹, ¹Loma Linda University Medical Center, Redlands, CA, ²UC Riverside School of Medicine, Riverside, CA, ³Loma Linda University Health System, Loma Linda, CA, ⁴Loma Linda University Medical Center, Loma Linda, CA, ⁵Loma Linda University Health, Department of Rheumatology, Loma Linda, CA, ⁶Loma Linda University, Loma Linda, CA, ⁷Loma Linda University School of Medicine, Redlands, CA, ⁸Loma Linda University Medical Center, Loma Linda, ⁹Loma Linda University, Loma Linda
Background/Purpose: Cytokine release syndrome (CRS) is a condition characterized by a sepsis-like condition and laboratory abnormalities such as high ferritin, low ESR, and low fibrinogen…
Abstract Number: 1280 • ACR Convergence 2020
COVID-19 Infections May Increase the Risk of SLE Flares
Leila Khalili¹, Yevgeniya Gartshteyn², Nancyanne Schmidt³, Teja Kapoor⁴, Laura Geraldino-Pardilla⁵ and Anca Askanase³, ¹Columbia University Medical Center, New York, NY, ²Columbia University College of Physicians and Surgeons, Glen Rock, NJ, ³Columbia University College of Physicians and Surgeons, New York, NY, ⁴Columbia University College of Physicians and Surgeons, Leonia, NJ, ⁵Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York
Background/Purpose: COVID-19 has overwhelmed the healthcare systems in New York City. Initial data from the Columbia Lupus Cohort suggests that 4% of patients with systemic…
Abstract Number: 1686 • ACR Convergence 2020
The COV-ASAKI Survey from the Pediatric Tuscany Network During COVID-19 Era
Maria Vincenza Mastrolia¹, Rino Agostiniani², Chiara Azzari³, Roberto Bernardini⁴, Ugo Bottone⁵, Giovanni Battista Calabri⁶, Flavio Civitelli⁷, Rita Consolini⁸, Roberto Danieli⁹, Rosalia Di Silvio¹⁰, Susanna Falorni¹¹, Luigi Gagliardi¹², Salvatore Grosso¹³, Marco Martini¹⁴, Graziano Memmini¹⁵, Marco Pezzati¹⁶, Giovanni Suriano¹⁷, Luca Tafi¹⁸, Angelina Vaccaro¹⁹, Pier Luigi Vasarri²⁰ and Gabriele Simonini²¹, ¹Rheumatology Unit, Meyer Children's University Hospital, Firenze, Italy, Florence, Toscana, Italy, ²Paediatric Unit, San Jacopo Hospital, Pistoia, Italy, Pistoia, Toscana, Italy, ³Paediatric Immunology Unit, Department of Health Sciences, Meyer Children’s University Hospital, Firenze, Italy, Florence, Toscana, Italy, ⁴Paediatric Unit, San Giuseppe Hospital, Empoli, Italy, Empoli, Toscana, Italy, ⁵Division of Neonatology and Pediatrics, Lotti Hospital, Pontedera, AUSL Toscana Nord Ovest, Pisa, Italy, Pisa, Toscana, Italy, ⁶Cardiologic Unit, Meyer Children’s University Hospital, Firenze, Italy, Florence, Toscana, Italy, ⁷Division of Neonatology and Pediatrics, Montepulciano Hospital, Montepulciano, AUSL Sud Est Toscana, Siena, Italy., Siena, Toscana, Italy, ⁸Section of clinical and laboratory Immunology, Department of clinical and experimental Medicine, University of Pisa, Italy, Pisa, Italy, ⁹Division of Neonatology and Pediatrics, Spedali Riuniti di Livorno, Livorno, AUSL Toscana Nord Ovest, Pisa, Italy, Livorno, Toscana, Italy, ¹⁰Paediatric Unit, Mugello Hospital, Borgo San Lorenzo, Firenze, Italy, Florence, Toscana, Italy, ¹¹Paediatric Unit, Misericordia Hospital, Grosseto, Italy, Grosseto, Italy, ¹²Division of Neonatology and Pediatrics, Ospedale Versilia Hospital, Viareggio, AUSL Toscana Nord Ovest, Pisa, Italy, Viareggio, Toscana, Italy, ¹³Clinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy, Siena, Toscana, Italy, ¹⁴Paediatric Unit, San Donato Hospital, Arezzo, Italy, Arezzo, Toscana, Italy, ¹⁵Division of Neonatology and Pediatrics, Apuane Hospital, Massa Carrara, AUSL Toscana Nord Ovest, Pisa, Italy, Massa Carrara, Toscana, Italy, ¹⁶Paediatric Unit, Santa Maria Annunziata Hospital, Bagno a Ripoli, Firenze, Italy, Florence, Toscana, Italy, ¹⁷Division of Neonatology and Pediatrics, Cecina Hospital, Cecina, AUSL Toscana Nord Ovest, Pisa, Italy, Cecina, Toscana, Italy, ¹⁸Paediatric and Neonatal Unit, Valdarno Hospital, Montevarchi, Arezzo, Italy, Arezzo, Toscana, Italy, ¹⁹Division of Neonatology and Pediatrics, San Luca Hospital, Lucca, AUSL Toscana Nord Ovest, Pisa, Italy, Lucca, Toscana, Italy, ²⁰Paediatric and Neonatologic Unit, Santo Stefano Hospital, Prato, Italy, Prato, Toscana, Italy, ²¹Rheumatology Unit, Meyer Children's University Hospital, Florence; NEUROFARBA Department, University of Florence, Italy, Florence, Italy
Background/Purpose: At the end of April 2020, national and international Pediatrics scientific societies diffused an alert about a rise in the number of pediatric severe,…
Abstract Number: 0017 • ACR Convergence 2020
Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications
Daniel Watrous¹, Glenn Parris², Priya Reddy³, Jeffrey Alper⁴, Fenglong Xie⁵, Maria (Maio) Danila⁶, Michael George⁷, William Nowell⁸, Joel Kallich⁹ and Jeffrey R Curtis¹⁰, ¹Sierra Pacific Arthritis, Visalia, CA, ²PARRIS & ASSOCIATES, Lilburn, GA, ³Southwest Florida Rheumatology, Riverview, FL, ⁴Medallion Clinical Research Institute, LLC, Naples, FL, ⁵University of Alabama at Birmingham, Birmingham, AL, ⁶University of Alabama at Birmingham (UAB), Birmingham, AL, ⁷University of Pennsylvania, Philadelphia, PA, ⁸Global Healthy Living Foundation, New York City, NY, ⁹Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, ¹⁰Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The global COVID19 pandemic has had a major impact on healthcare. The effect on rheumatology patients and providers is unclear, as is the role…
Abstract Number: 0442 • ACR Convergence 2020
Disparities in CoronaViridae Infection Are Readily Apparent in Rheumatology Patients Despite Use of Hydroxychloquine And/or Methotrexate
Maria Antonelli¹ and Nora Singer², ¹MHMC/CWRU, Cleveland, OH, ²The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH
Background/Purpose: In the initial months of the SARS CoV2/COVID19 pandemic, broad use of off-label therapy with hydroxychloroquine (HCQ) was prescribed to reduce CoV2-related morbidity and…
Abstract Number: 0597 • ACR Convergence 2020
Telemedicine in Pediatric Rheumatology During COVID-19: The PR-COIN Experience
Y. Ingrid Goh¹, Nancy Pan², Julia Harris³, Andrew Warmin⁴, Janalee Taylor⁴, Sheetal Vora⁵, Fatima Barbar-Smiley⁶, Jon Burnham⁷, Tzielan Lee⁸, Cagri Yildirim-Toruner⁹, Kendra Wiegand¹⁰ and Esi Morgan¹¹, ¹The Hospital for Sick Children, Toronto, ON, Canada, ²Hospital for Special Surgery, New York, NY, ³Children's Mercy Kansas City, Overland Park, KS, ⁴Cincinnati Children's Hospital, Cincinnati, OH, ⁵Atrium Health Levine Children's Hospital, Charlotte, NC, ⁶Nationwide Children's Hospital/The Ohio State University, Columbus, OH, ⁷Children's Hospital of Philadelphia, Philadelphia, PA, ⁸Stanford University School of Medicine, Palo Alto, CA, ⁹Nationwide Children's Hospital, Houston, TX, ¹⁰Cincinnati Children's Hospital, Cincinnati, ¹¹Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Background/Purpose: Healthcare teams were forced to rethink the way they practiced medicine during the COVID-19 pandemic. Many teams transitioned from conducting in-person visits to virtual…
Abstract Number: 0640 • ACR Convergence 2020
Covid-19 and Rheumatic and Musculoskeletal Disease Patients: Infection Rates, Attitudes and Medication Adherence
Kieran Murray¹, Sean Quinn², Matthew Turk², Anna O'Rourke³, Eamonn Molloy¹, Lorraine O'Neill⁴, Anne Mongey⁵, Ursula Fearon⁶ and Douglas Veale⁷, ¹Saint Vincent's University Hospital, Dublin 4, Dublin, Ireland, ²Saint Vincent's University Hospital, Dublin 4, Ireland, ³Saint James' University Hospital, Dublin 6, Ireland, ⁴Saint Vincent's University Hospital, Dublin, Ireland, ⁵Saint Vincent's University Hospital, Co Dublin, Ireland, ⁶Molecular Rheumatology, Trinity College Dublin, Dublin, Dublin, Ireland, ⁷EULAR Centre for Arthritis and Rheumatic Diseases, St Vincents University Hospital, UCD, Dublin, Dublin, Ireland
Background/Purpose: Covid-19 has caused >400,000 deaths. The relationship between RMDs, immunosuppressive medications and Covid-19 is unclear. This study explores Covid-19 prevalence, DMARD adherence, information sources…
Abstract Number: 1301 • ACR Convergence 2020
Characterizing How SLE Patients Access Health Information Pre and During COVID-19
Francesca Cardwell¹, Susan Elliott², May Choi³, Ricky Chin⁴ and Ann Clarke⁵, ¹University of Waterloo, Burlington, ON, Canada, ²University of Waterloo, Waterloo, ON, Canada, ³Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ⁴University of Calgary, Calgary, AB, Canada, ⁵University of Calgary, Calgary, Canada
Background/Purpose: The spread of misinformation related to COVID-19 has been especially acute for SLE patients as unsubstantiated claims regarding the efficacy of antimalarials for COVID-19…
Abstract Number: 1769 • ACR Convergence 2020
Patient-reported COVID-19 Infection in Pregnant Women with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance Patient Experience Survey
Jonathan Hausmann¹, Emily Sirotich², Bonnie Bermas³, Megan Clowse⁴, Milena Gianfrancesco⁵, Pedro M Machado⁶, Helen Robinson⁷, Anja Strangfeld⁸, Jinoos Yazdany⁹ and Philip Robinson¹⁰, ¹Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, ²McMaster University, Hamilton, ON, Canada, ³UTSouthwestern.edu, Dallas, TX, ⁴Duke University, Chapel Hill, NC, ⁵University of California, San Francisco, San Francisco, CA, ⁶University College London, London, United Kingdom, ⁷University of Queensland School of Medicine, HERSTON, Queensland, Australia, ⁸German Rheumatism Research Center, Berlin, Germany, ⁹UCSF, San Francisco, CA, ¹⁰University of Queensland, Herston, Queensland, Australia
Background/Purpose: The impact of COVID-19 on pregnancy in patients with rheumatic disease is unknown. We describe COVID-19 outcomes in pregnant women with rheumatic disease who…
Abstract Number: 0018 • ACR Convergence 2020
PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City
Gregory Vitone¹, Marianna Frey², Candace Feldman³, Lindsay Lally², Anne Bass⁴, Jane Salmon², Mary Crow², Michael Lockshin⁵, Vivian Bykerk², Medha Barbhaiya⁵ and Lisa Mandl², ¹Hospital for Special Surgery, New York, ²Hospital for Special Surgery, New York, NY, ³Brigham and Women's Hospital, Boston, MA, ⁴Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁵Hospital for Special Surgery, Barbara Volcker Center for Women and Rheumatic Diseases, New York, NY
Background/Purpose: Little is known about the general health and wellbeing of patients with systemic rheumatic diseases (SRD) during the COVID pandemic. We sought to compare…
Abstract Number: 0443 • ACR Convergence 2020
Impact of the COVID-19 Pandemic on Racial and Ethnic Minority Groups Diagnosed with Rheumatic Diseases
Emily Sirotich¹, Teresa Semalulu¹, Kevin Kennedy², Salman Surangiwala³, Maggie Larche¹, Jean Liew⁴, Mitchell Levine², Graeme Reed⁵, Naira Ikram⁶, Carly Harrison⁷, Richard Howard⁸, Rashmi Sinha⁹, Monique Gore-Massy¹⁰ and Jonathan Hausmann¹¹, ¹McMaster University, Hamilton, ON, Canada, ²McMaster University, Hamilton, Canada, ³Queen’s School of Medicine, Kingston, Canada, ⁴University of Washington, Seattle, ⁵Canadian Spondylitis Association, Vancouver, Canada, ⁶Duke University, Durham, ⁷Lupus Chat, NA, ⁸Spondylitis Association of America, Van Nuys, CA, ⁹SJIA Foundation, Cincinnati, ¹⁰Lupus Foundation of America, Brooklyn, NY, ¹¹Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA
Background/Purpose: The COVID-19 pandemic has exacerbated structural and systematic barriers in access to healthcare for racial and ethnic minorities. The impact of these increased barriers…
Abstract Number: 0599 • ACR Convergence 2020
Evaluation of Telephone Consultations in Germany as an Additional Tool in Outpatient Rheumatology Clinics During the COVID-19 Pandemic
Ulrich Drott¹, Axel Braner¹, Thomas Kollewe², Harald Burkhardt³ and Florian Meier¹, ¹Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt, Germany, ²J. W. Goethe-Universität Frankfurt, FB Medizin, Frankfurter Arbeitsstelle für Medizindidaktik, Frankfurt, Germany, Frankfurt, Germany, ³Department of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany, Frankfurt am Main, Germany
Background/Purpose: The Covid-19 pandemic holds multiple challenges for the healthcare system. Quick adoptions and adjustments are the mainstays during these times. Hygiene management and plans…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.